← Back to Search

Educational Intervention for Breast Cancer Risk

N/A
Waitlist Available
Led By Kent Hoskins, M.D.
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No prior history of breast cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test whether an educational intervention can help patients understand their cancer risk.

Who is the study for?
This trial is for African American women aged 25-69 who are recommended for genetic counseling based on a cancer risk assessment done during their mammogram at UI Health. They must not have had breast cancer before or previous genetic counseling for hereditary breast cancer risk, and they should be able to consent and complete surveys in English.Check my eligibility
What is being tested?
The study is testing the effectiveness of an educational video intervention used alongside a genetic risk assessment during mammography appointments to see if it increases the uptake of genetic counseling among participants.See study design
What are the potential side effects?
Since this trial involves an educational video as an intervention, there are no direct medical side effects associated with it. However, participants may experience emotional or psychological responses to learning about their breast cancer risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never had breast cancer before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Knowledge and intentions regarding genetic counseling
Secondary outcome measures
Attendance at genetic counseling appointment

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open LabelExperimental Treatment1 Intervention
Educational genetic counseling video
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational video
2014
Completed Phase 3
~3650

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
614 Previous Clinical Trials
1,561,391 Total Patients Enrolled
Kent Hoskins, M.D.Principal InvestigatorUniversity of Illinois at Chicago
1 Previous Clinical Trials
13 Total Patients Enrolled

Media Library

Open Label Clinical Trial Eligibility Overview. Trial Name: NCT04082117 — N/A
Breast Cancer Risk Research Study Groups: Open Label
Breast Cancer Risk Clinical Trial 2023: Open Label Highlights & Side Effects. Trial Name: NCT04082117 — N/A
Open Label 2023 Treatment Timeline for Medical Study. Trial Name: NCT04082117 — N/A
~120 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top